gabexate has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammendola, M; De Sarro, G; Gadaleta, CD; Leporini, C; Marech, I; Ranieri, G; Russo, E; Sacco, R; Sammarco, G; Scognamillo, G | 1 |
1 review(s) available for gabexate and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide
| Article | Year |
|---|---|
Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy.
Topics: Angiogenesis Inhibitors; Cell Proliferation; Gabexate; Humans; Inflammation; Mast Cells; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Tryptases; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2014 |